WILSON TROY EDWARD
Reporting owner on Forms 3, 4 and 5, CIK 1589597.
WILSON TROY EDWARD reported on 1 issuer in 2 filings, the latest a Form 4/A filed 2026-11-17.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| KURA · Kura Oncology, Inc.CIK 1422143 | director, officer (President and CEO) | 2 | 2026-11-17 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| KURA · Kura Oncology, Inc.Common Stock | 2026-11-16 | P bought | +101,119 | $7.42 | 679,194 | Form 4/A |
| KURA · Kura Oncology, Inc.Common Stock, superseded by an amendment | 2026-11-16 | P bought | +101,119 | $7.42 | 635,456 | Form 4 |
| KURA · Kura Oncology, Inc.Common Stock | 2026-11-13 | P bought | +98,881 | $7.63 | 578,075 | Form 4/A |
| KURA · Kura Oncology, Inc.Common Stock, holding | 300,000 | Form 4/A | ||||
| KURA · Kura Oncology, Inc.Common Stock, holding | 435,456 | Form 4/A | ||||
| KURA · Kura Oncology, Inc.Common Stock, superseded by an amendment | 2026-11-13 | P bought | +98,881 | $7.63 | 534,337 | Form 4 |
| KURA · Kura Oncology, Inc.Common Stock, holding, superseded by an amendment | 479,194 | Form 4 | ||||
| KURA · Kura Oncology, Inc.Common Stock, holding, superseded by an amendment | 300,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4/A 0001193125-26-465499 | Kura Oncology, Inc. | 2026-11-17 | ||
| Form 4 0001193125-26-464166 | Kura Oncology, Inc. | 2026-11-16 |